192 related articles for article (PubMed ID: 20569000)
1. Two novel monoclonal antibodies against human CD133-2: distinct epitopes and agonist activity to enhance growth of CD133 expression cells in vitro.
Wang J; Li F; Zhang G; Chen Y; Hu Y; Chen X; Lu B; Zhang X
Hybridoma (Larchmt); 2010 Jun; 29(3):241-9. PubMed ID: 20569000
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel monoclonal antibody recognizing CD133.
Swaminathan SK; Olin MR; Forster CL; Cruz KS; Panyam J; Ohlfest JR
J Immunol Methods; 2010 Sep; 361(1-2):110-5. PubMed ID: 20674577
[TBL] [Abstract][Full Text] [Related]
3. Anti-human CD133 monoclonal antibody that could inhibit the proliferation of colorectal cancer cells.
Chen W; Li F; Xue ZM; Wu HR
Hybridoma (Larchmt); 2010 Aug; 29(4):305-10. PubMed ID: 20715988
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts.
Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R
Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587
[TBL] [Abstract][Full Text] [Related]
5. Human trophoblast contains an intracellular protein reactive with an antibody against CD133--a novel marker for trophoblast.
Pötgens AJ; Bolte M; Huppertz B; Kaufmann P; Frank HG
Placenta; 2001 Aug; 22(7):639-45. PubMed ID: 11504532
[TBL] [Abstract][Full Text] [Related]
6. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
[TBL] [Abstract][Full Text] [Related]
7. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
[TBL] [Abstract][Full Text] [Related]
8. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.
Bidlingmaier S; Zhu X; Liu B
J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813
[TBL] [Abstract][Full Text] [Related]
9. Establishment of CMab-43, a Sensitive and Specific Anti-CD133 Monoclonal Antibody, for Immunohistochemistry.
Itai S; Fujii Y; Nakamura T; Chang YW; Yanaka M; Saidoh N; Handa S; Suzuki H; Harada H; Yamada S; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):231-235. PubMed ID: 28910211
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18.
Pötgens AJ; Schmitz U; Kaufmann P; Frank HG
J Histochem Cytochem; 2002 Aug; 50(8):1131-4. PubMed ID: 12133915
[TBL] [Abstract][Full Text] [Related]
11. [The CD133 polyclonal antibody generation and cancer stem cells identification].
Tian JL; Cai PL; Xia XQ; Li FH; Wang DH; Chen MN
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):422-6. PubMed ID: 21827013
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines.
Jaksch M; Múnera J; Bajpai R; Terskikh A; Oshima RG
Cancer Res; 2008 Oct; 68(19):7882-6. PubMed ID: 18829544
[TBL] [Abstract][Full Text] [Related]
13. Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): assessment of cross-reacting monoclonal antibodies.
Shibata H; Hanazono Y; Ageyama N; Nagashima T; Ueda Y; Hasegawa M; Ozawa K; Yoshikawa Y; Terao K
Am J Primatol; 2003 Sep; 61(1):3-12. PubMed ID: 12966515
[TBL] [Abstract][Full Text] [Related]
14. Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors.
Angelotti ML; Lazzeri E; Lasagni L; Romagnani P
Kidney Int; 2010 Sep; 78(6):620-1; author reply 621. PubMed ID: 20805819
[No Abstract] [Full Text] [Related]
15. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein.
Osmond TL; Broadley KW; McConnell MJ
Int J Mol Med; 2010 Jun; 25(6):883-8. PubMed ID: 20428792
[TBL] [Abstract][Full Text] [Related]
16. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
17. CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential.
Li G; Liu C; Yuan J; Xiao X; Tang N; Hao J; Wang H; Bian X; Deng Y; Ding Y
Clin Exp Metastasis; 2010 Oct; 27(7):517-27. PubMed ID: 20617370
[TBL] [Abstract][Full Text] [Related]
18. RNA aptamers targeting cancer stem cell marker CD133.
Shigdar S; Qiao L; Zhou SF; Xiang D; Wang T; Li Y; Lim LY; Kong L; Li L; Duan W
Cancer Lett; 2013 Mar; 330(1):84-95. PubMed ID: 23196060
[TBL] [Abstract][Full Text] [Related]
19. Photochemical internalization (PCI) of immunotoxins targeting CD133 is specific and highly potent at femtomolar levels in cells with cancer stem cell properties.
Bostad M; Berg K; Høgset A; Skarpen E; Stenmark H; Selbo PK
J Control Release; 2013 Jun; 168(3):317-26. PubMed ID: 23567040
[TBL] [Abstract][Full Text] [Related]
20. Human CD133-positive hematopoietic progenitor cells initiate growth and metastasis of colorectal cancer cells.
Zhang C; Zhou C; Wu XJ; Yang M; Yang ZH; Xiong HZ; Zhou CP; Lu YX; Li Y; Li XN
Carcinogenesis; 2014 Dec; 35(12):2771-7. PubMed ID: 25269803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
